Sign In
Buy GLSI
Greenwich LifeSciences Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 3.91M and sold 0 GLSI shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
100.00 |
| ● Buy | 3.91M shares |
| ● Sell | 0 shares |
|
100% Buy Activity
Negligible or No Correlation
|
|
No Significant SignalsNo statistically significant buy or sell signals detected in recent insider data. |
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Jan 02, 2025 Buy |
Patel Snehal CEO And CFO |
2 000 Value: $23.9K |
||
|
Jan 02, 2025 Buy |
Patel Snehal CEO And CFO |
2 000 Value: $23.9K |
||
|
Dec 31, 2024 Buy |
Patel Snehal CEO And CFO |
2 400 Value: $27.3K |
||
|
Dec 31, 2024 Buy |
Patel Snehal CEO And CFO |
2 400 Value: $27.3K |
||
|
Dec 30, 2024 Buy |
Patel Snehal CEO And CFO |
3 200 Value: $35.6K |
||
|
Dec 30, 2024 Buy |
Patel Snehal CEO And CFO |
3 200 Value: $35.6K |
||
|
Dec 24, 2024 Buy |
Daugherty Frank Joseph Chief Medical Officer |
104 890 Value: $1.28M |
||
|
Dec 24, 2024 Buy |
Hallock Kenneth Director |
41 349 Value: $502.8K |
||
|
Dec 24, 2024 Buy |
Patel Snehal CEO And CFO |
25 008 Value: $304.1K |
||
|
Dec 24, 2024 Buy |
Patel Snehal CEO And CFO |
1 148 723 Value: $14.0M |
||
|
Dec 24, 2024 Buy |
Rothe Eric Director |
41 349 Value: $502.8K |
||
|
Dec 24, 2024 Buy |
Thompson Jaye Vp Clinical Reg Affairs |
149 818 Value: $1.82M |
||
|
Dec 24, 2024 Buy |
Mcwilliams David Director |
61 984 Value: $753.7K |
||
|
Dec 24, 2024 Buy |
Mcwilliams David Director |
61 984 Value: $753.7K |
||
|
Dec 24, 2024 Buy |
Thompson Jaye Vp Clinical Reg Affairs |
149 818 Value: $1.82M |
||
|
Dec 24, 2024 Buy |
Rothe Eric Director |
41 349 Value: $502.8K |
||
|
Dec 24, 2024 Buy |
Patel Snehal CEO And CFO |
1 148 723 Value: $14.0M |
||
|
Dec 24, 2024 Buy |
Patel Snehal CEO And CFO |
25 008 Value: $304.1K |
||
|
Dec 24, 2024 Buy |
Hallock Kenneth Director |
41 349 Value: $502.8K |
||
|
Dec 24, 2024 Buy |
Daugherty Frank Joseph Chief Medical Officer |
104 890 Value: $1.28M |
||
|
Nov 21, 2024 Buy |
Thompson Jaye Vp Clinical Reg Affairs |
1 000 Value: $12.9K |
||
|
Nov 21, 2024 Buy |
Thompson Jaye Vp Clinical Reg Affairs |
1 000 Value: $12.9K |
||
|
Sep 26, 2024 Buy |
Patel Snehal CEO And CFO |
1 500 Value: $21.9K |
||
|
Sep 26, 2024 Buy |
Patel Snehal CEO And CFO |
1 500 Value: $21.9K |
||
|
Aug 12, 2024 Buy |
Thompson Jaye Vp Clinical Reg Affairs |
800 Value: $11.1K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
